课题基金 / 基金详情

项目摘要

项目成果

Jonathan D. Kurtis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall goal of this proposal is to understand the mechanism(s) of poor pregnancy outcome in schistosome infected women. Healthy, successful pregnancies are characterized by a placental microenvironment that is biased toward a T-helper cell type 2 (Th2) cytokine milieu [1, 2]. Human infection with schistosomiasis results in the elaboration of pro-inflammatory cytokines including TNF-? [11-15], IL-6 [16], and IFN-? [12, 17] that are detected in the systemic circulation. Each of these cytokines has been implicated in fetal growth restriction in human studies [18-21]. In a pilot study in N=97 pregnant women living in a Schistosoma japonicum endemic area of the Philippines, we demonstrated that women with moderate or high intensity S. japonicum infection gave birth to newborns with birth weights that were 460 grams lower than women with low intensity or no infection, after adjusting for maternal height, gestational age, and geo-helminth infections (N=60, P = 0.06). Furthermore, moderately infected women had increased placental blood pro-inflammatory cytokine levels, increased trophoblast production of pro-inflammatory cytokines, and increased trophoblast apoptosis compared to uninfected women. In this proposal, we will utilize a murine model of S. mansoni to understand the mechanisms of trophoblast activation during schistosome infection. We hypothesize that schistsomes secret ligands into the maternal circulation that activate Toll-like receptors (TLRs) on trophoblasts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying the targets of protective immunity to severe falciparum malaria
  • 批准号:
    10893666
  • 项目类别:
  • 资助金额:
    $50.01万
  • 财政年份:
    2023
  • 负责人:
    Jonathan D. Kurtis
  • 依托单位:
Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria
  • 批准号:
    9977935
  • 项目类别:
  • 资助金额:
    $65.55万
  • 财政年份:
    2017
  • 负责人:
    Jonathan D. Kurtis
  • 依托单位:
One Health Vaccine Development for Bovine and Human Schistosomiasis
  • 批准号:
    10019231
  • 项目类别:
  • 资助金额:
    $5.64万
  • 财政年份:
    2017
  • 负责人:
    Jonathan D. Kurtis
  • 依托单位:
Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria
  • 批准号:
    10227778
  • 项目类别:
  • 资助金额:
    $66.83万
  • 财政年份:
    2017
  • 负责人:
    Jonathan D. Kurtis
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: